Cargando…
Thymalfasin therapy accelerates COVID-19 pneumonia rehabilitation through anti-inflammatory mechanisms
INTRODUCTION: Thymosin drugs are commonly used for the treatment of viral infections due to their immunomodulatory effects. The comprehensive clinical efficacy of Thymalfasin therapy for COVID-19 associated pneumonia is not yet fully researched, another issue, whether the use of thymosin drugs can r...
Autores principales: | Wang, Zirui, Wang, Cong, Fei, Xiaohua, Wu, Haixing, Niu, Peiqin, Shen, Changxing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10518946/ https://www.ncbi.nlm.nih.gov/pubmed/37743481 http://dx.doi.org/10.1186/s41479-023-00116-6 |
Ejemplares similares
-
Thymalfasin, a promising adjuvant therapy in small hepatocellular carcinoma after liver resection
por: He, Chao, et al.
Publicado: (2017) -
Effect of thymalfasin (Thymosin-α-1) on reversing lymphocytopenia among patients with COVID-19
por: Benitez, Gregorio, et al.
Publicado: (2023) -
A pilot trial of Thymalfasin (Ta1) to prevent covid-19 infection and morbidities in renal dialysis patients: Preliminary report()
por: Tuthill, Cynthia W., et al.
Publicado: (2023) -
Novel strategy of sirolimus plus thymalfasin and huaier granule on tumor recurrence of hepatocellular carcinoma beyond the UCSF criteria following liver transplantation: A single center experience
por: Zhou, Lin, et al.
Publicado: (2018) -
Reduction of FoxP3(+) Tregs by an immunosuppressive protocol of rapamycin plus Thymalfasin and Huaier extract predicts positive survival benefits in a rat model of hepatocellular carcinoma
por: Zhou, Lin, et al.
Publicado: (2020)